To view PDF documents
External links included in this website should not be construed as an official endorsement of the views contained therein.
|
What's New
May 2013
April 2013
- Lipomed (April 23, 2013)
- Fisher
Clinical Services, Inc. (April 23, 2013)
- Research Triangle Institute (April 23, 2013)
- Wildlife Laboratories, Inc. (April 23, 2013)
- S & B Pharma Inc. (April 23, 2013)
- Alltech Associates, Inc. (April 23, 2013)
- PCAS-Nanosyn, LLC (April 23, 2013)
- Cayman Chemical Company (April 23, 2013)
- Rhodes
Technologies (April 19, 2013)
- Catalent CTS., Inc. (April 19, 2013)
- Almac
Clinical Services, Inc., (ACSI) (April 19, 2013)
- GE
Healthcare (April 19, 2013)
- Nebraska State Penitentiary (April 19, 2013)
- Penick Corporaton (April 19, 2013)
- Rhodes Technologies (April 19, 2013)
- American Radiolabeled Chemicals, Inc. (April 19, 2013)
- Navinta, LLC. (April 19, 2013)
- National Center for Natural Products Research-NIDA MProject (April 19, 2013)
- Schedules of Controlled Substances: Temporary Placement of Three
Synthetic Cannabinoids Into Schedule I (April 12, 2013)
- Schedules of Controlled Substances: Placement of Methylone Into
Schedule I (April 12, 2013)
- 60-Day Notice - Comments Requested: National Drug Threat Survey; Extension With Change
of a Previously Approved Collection (April 3, 2013)
March 2013
- 60-Day Notice - Comments Requested: Import/Export Declaration for List I and List II
Chemicals, DEA Forms 486 and 486A (March 29, 2013)
- Gary Alfred Shearer, M.D.; Decision And Order (March 28, 2013)
- Pawan Kumar Jain, M.D.; Decision And Order (March 28, 2013)
- Stepan
Company (March 28, 2013)
- SA INTL
GMBH C/O., Sigma Aldrich Co. LLC (March 28, 2013)
- Johnson Matthey, Inc. (March 28, 2013)
- Mylan
Pharmaceuticals, Inc. (March 28, 2013)
- Patheon Pharmaceuticals, Inc. (March 28, 2013)
- Johnson Matthey Pharmaceutical Materials, Inc. (March 28, 2013)
- Siemens Healthcare Diagnostics, Inc. (March 28, 2013)
- Electronic Prescriptions for Controlled Substances Notice of
Approved Certification Process (March 26, 2013)
- Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV (March 25, 2013)
- Noramco
Inc. (March 20, 2013)
- United
States Pharmacopeial Convention (March 20, 2013)
- Noramco, Inc. (March 20, 2013)
- Watson
Pharma, Inc. (March 20, 2013)
- Morton Grove Pharmaceuticals (March 20, 2013)
- Noramco, Inc. (March 20, 2013)
- 30-Day Notice - Comments Requested: Reporting and Recordkeeping for Digital
Certificates (March 15, 2013)
- Johnson Matthey, Inc. (March 14, 2013)
- Meridian Medical Technologies (March 13, 2013)
- Hospira Inc. (March 13, 2013)
- Johnson Matthey, Inc., Pharmaceuticals Materials (March 13, 2013)
February 2013
- Brian Earl Cressman, M.D.; Decision and Order (February 21, 2013)
- John V. Scalera; Decision and Order (February 21, 2013)
- Meda
Pharmaceuticals, Inc. (February 21, 2013)
- Mallinckrodt, LLC. (February 21, 2013)
- Caraco
Pharmaceutical Laboratories, LTD. (February 21, 2013)
- Mallinckrodt, LLC (February 21, 2013)
- Pharmagra Labs, Inc. (February 21, 2013)
- Sigma Aldrich Research Biochemicals, Inc. (February 21, 2013)
- GE
Healthcare (February 21, 2013)
- Alltech Associates, Inc. (February 21, 2013)
- Cody Laboratories, Inc. (February 21, 2013)
- Cedarburg Pharmaceuticals, Inc. (February 21, 2013)
- INB Hauser Pharmaceutical Services, Inc. (February 21, 2013)
- 30-Day Notice - Comments Requested: Application for Individual Manufacturing Quota for
a Basic Class of Controlled Substance and for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine (February 8, 2013)
- 30-Day Notice - Comments Requested: Application for Procurement Quota for Controlled
Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine (February 8, 2013)
- 30-Day Notice - Comments Requested: Report of Mail Order Transaction (February 8, 2013)
- GE
Healthcare (February 6, 2013)
- Sanjay Trivedi, M.D.; Decision and Order (February 4, 2013)
January 2013
- 30-Day Notice - Comments Requested: Application for Registration Under Domestic
Chemical Diversion Control Act of 1993 and Renewal Application for
Registration Under Domestic Chemical Diversion Control Act of 1993; DEA
Forms 510 and 510a (January 30, 2013)
- 30-Day Notice - Comments Requested: Annual Reporting Requirement for Manufacturers of
Listed Chemicals (January 30, 2013)
- PCAS-Nanosyn, LLC (January 30, 2013)
- Mylan
Technologies, Inc. (January 29, 2013)
- Alkermes Gainesville, LLC (January 29, 2013)
- Fisher
Clinical Services, Inc. (January 25, 2013)
- Nebraska State Penitentiary (January 25, 2013)
- R & D
Systems, Inc. (January 25, 2013)
- Myoderm (January 25, 2013)
- Chattem Chemicals, Inc. (January 25, 2013)
- Cerilliant Corporation (January 25, 2013)
- Sigma Aldrich Research Biochemicals, Inc. (January 25, 2013)
- Johnson Matthey, Inc. (January 25, 2013)
- Ampac Fine Chemicals, LLC (January 25, 2013)
- Siegfried (USA) (January 25, 2013)
- Chemic Laboratories, Inc. (January 25, 2013)
- Noramco, Inc. (January 25, 2013)
- Cerilliant Corporation (January 25, 2013)
- Morton Grove Pharmaceuticals (January 25, 2013)
- Order With Opportunity for Comment - Exempt Chemical Preparations Under the Controlled Substances Act (January 22, 2013)
- 30-Day Notice - Comments Requested: Collection of Laboratory Analysis Data on Drug
Samples Tested by Non-Federal (State and Local) Crime Laboratories (January 14, 2013)
- 60-Day Notice - Comments Requested: Reporting and Recordkeeping for Digital
Certificates (January 11, 2013)
- Establishment of Drug Codes for 26 Substances (January 4, 2013)
December 2012
- ISP
Freetown Fine Chemicals (December 27, 2012)
- Disposal of Controlled Substances (December 21, 2012)
- Hospira (December 21, 2012)
- Fisher Clinical Services, Inc. (December 21, 2012)
- AMRI Rensselaer, Inc. (December 21, 2012)
- Rhodes Technologies (December 21, 2012)
- Euticals, Inc. (December 21, 2012)
- Chemtos, LLC (December 21, 2012)
- Halo Pharmaceutical, Inc. (December 21, 2012)
- Schedules of Controlled Substances: Placement of Lorcaserin Into
Schedule IV (December 19, 2012)
- Stephanie A. Tarapchak, M.D.; Decision and Order (December 11, 2012)
- Robert M. Brodkin, D.P.M.; Decision and Order (December 11, 2012)
- Pharmacy Diversion Awareness Conference - Indianapolis, Indiana (December 8 & 9, 2012)
- 60-Day Notice - Comments Requested: Report of Mail Order Transaction (December 7, 2012)
- Jeffery J. Becker, D.D.S., and Jeffery J. Becker, D.D.S.,
Affordable Care Decision and Order (December 5, 2012)
- Amy S. Benjamin, N.P.; Decision and Order (December 5, 2012)
- Mylan
Pharmaceuticals, Inc. (December 5, 2012)
- Fisher
Clinical Services, Inc. (December 5, 2012)
- Siemens Healthcare Diagnostics, Inc. (December 5, 2012)
- ISP
Inc (December 5, 2012)
- 60-Day Notice - Comments Requested: Application for Individual Manufacturing Quota for
a Basic Class of Controlled Substance and for Ephedrine,
Pseudoephedrine, and Phenylpropanolamine (December 4, 2012)
- 60-Day Notice - Comments Requested: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine DEA Form 250 (December 4, 2012)
November 2012
- Johnson
Matthey, Inc. (November 27, 2012)
- Siegfried (USA), LLC (November 27, 2012)
- Norac (November 27, 2012)
- 60-Day Notice - Comments Requested: Application for Registration Under Domestic
Chemical Diversion Control Act of 1993 and Renewal Application for
Registration Under Domestic Chemical Diversion Control Act of 1993 DEA
Forms 510 & 510A (November 26, 2012)
- 60-Day Notice - Comments Requested: Annual Reporting Requirement for Manufacturers of
Listed Chemicals (November 26, 2012)
- Cerilliant Corporation (November 23, 2012)
- Lipomed, Inc. (November 23, 2012)
- Mylan
Technologies, Inc. (November 23, 2012)
- Cayman Chemical Company (November 23, 2012)
- Alltech Associates, Inc. (November 23, 2012)
- Boehringer Ingelheim Chemicals, Inc. (November 23, 2012)
- Cayman Chemical Company (November 23, 2012)
- Cambrex Charles City, Inc. (November 23, 2012)
- Karen Paul Holley, M.D.; Decision and Order (November 15, 2012)
- 21st National Conference on Pharmaceutical and Chemical Diversion - Cincinnati, Ohio (November 14-15, 2012)
- Wayne D. Longmore, M.D.; Decision and Order (November 13, 2012)
- Larry Elbert Perry, M.D.; Decision and Order (November 13, 2012)
- Fernando Valle, M.D.; Decision and Order (November 13, 2012)
- Watson
Pharma, Inc. (November 13, 2012)
- SA
INTL GMBH C/O., Sigma Aldrich Co., LLC. (November 13, 2012)
- Cedarburg Pharmaceuticals, Inc. (November 13, 2012)
- Johnson Matthey Inc. (November 13, 2012)
- Wildlife Laboratories, Inc. (November 13, 2012)
- Nektar Therapeutics (November 13, 2012)
- Fisher
Clinical Services, Inc. (November 9, 2012)
- Boehringer Ingelheim Chemicals, Inc. (November 9, 2012)
- Noramco, Inc. (November 9, 2012)
- Johnson Matthey, Inc. (November 9, 2012)
- Cody Laboratories, Inc. (November 9, 2012)
- National Center For Natural Products Research (NIDA MPROJECT) (November 9, 2012)
- INB
Hauser Pharmaceutical Services, Inc. (November 9, 2012)
|
|
